Affiliations 

  • 1 Department of Surgery, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK
Int Surg, 1997 Jul-Sep;82(3):269-74.
PMID: 9372373

Abstract

Recent studies have demonstrated a reduction in the morbidity and mortality of pancreatic resection and improvement in the actuarial 5-year survival for patients with resected ductal adenocarcinoma. We reviewed the clinico-pathological characteristics of patients who underwent resection with curative intent for ductal adenocarcinoma of the pancreas between 1980 and 1993.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.